Difference between revisions of "Team:AFCM-Egypt"

 
(45 intermediate revisions by 2 users not shown)
Line 2: Line 2:
 
{{Template:AFCM-Egypt/main}}
 
{{Template:AFCM-Egypt/main}}
 
{{Template:AFCM-Egypt/owl.carousel}}
 
{{Template:AFCM-Egypt/owl.carousel}}
 +
{{Template:AFCM-Egypt/header}}
 
<html>
 
<html>
 
<head>
 
<head>
Line 11: Line 12:
 
     <meta name="viewport" content="width=device-width, initial-scale=1.0">
 
     <meta name="viewport" content="width=device-width, initial-scale=1.0">
 
     <style>
 
     <style>
 +
.HOME a {border: 1px solid #fff;
 +
    background: rgba(255,255,255, 0.3) !important}
 +
 
.fa-arrow-up:before {
 
.fa-arrow-up:before {
 
     content: "\f062";
 
     content: "\f062";
Line 24: Line 28:
 
     display: none;
 
     display: none;
 
     position: fixed;
 
     position: fixed;
−
     bottom: 20px;
+
     bottom: 50px;
 
     right: 10px;
 
     right: 10px;
 
     z-index: 99;
 
     z-index: 99;
Line 30: Line 34:
 
     outline: none;
 
     outline: none;
 
     background-color: transparent;
 
     background-color: transparent;
−
     color: #fff;
+
     color: #ffffff;
 
     cursor: pointer;
 
     cursor: pointer;
 
     padding: 5px 10px 5px 10px;
 
     padding: 5px 10px 5px 10px;
 
     border-radius: 10px;
 
     border-radius: 10px;
 +
}
 +
#myBtn:hover{
 +
color:#777;
 
}
 
}
 
         .buttons {
 
         .buttons {
Line 112: Line 119:
 
}
 
}
 
.btn-outline {
 
.btn-outline {
−
   background: #4a148c !important;
+
   background: rgba(255, 255, 255, .15) !important;
 
   font-size: 16px;
 
   font-size: 16px;
 
   -webkit-transition: 0.3s;
 
   -webkit-transition: 0.3s;
Line 151: Line 158:
 
</head>
 
</head>
 
<body>
 
<body>
−
    <section class="header" id="header">
 
−
        <nav class="navbar navbar-default navbar-fixed-top">
 
−
            <div class="container" style="width:90%">
 
−
                <div class="navbar-header">
 
−
                                        <button type="button" id="navbar-toggle" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar">
 
  
−
                        <span class="sr-only">Toggle navigation</span>
 
−
                        <span class="icon-bar"></span>
 
−
                        <span class="icon-bar"></span>
 
−
                        <span class="icon-bar"></span>
 
−
                    </button>
 
−
                   
 
−
               
 
−
                <div class="collapse navbar-collapse" id="navbar">
 
−
<a class="navbar-brand" href="https://2017.igem.org/Team:AFCM-Egypt"><span><img src="https://static.igem.org/mediawiki/2017/a/aa/AFCM-Egypt-LOGO.png" style="width:150px; height:150px;"></span></a>
 
−
                    <ul id="menu">
 
−
                        <li class="active"><a href="https://2017.igem.org/Team:AFCM-Egypt">HOME</a> </li>
 
−
                        <li>
 
−
                            <a>TEAM <span class="caret"></span></a>
 
−
                            <ul>
 
−
                                <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Meet_the_team">Meet The Team</a></li>
 
−
                                <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Collaborations">Collaborations</a></li>
 
−
                            </ul>
 
−
                        </li>
 
−
                        <li class="dropdown">
 
−
                            <a>PROJECT <span class="caret"></span></a>
 
−
                            <ul>
 
−
                                <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Description">Project Description</a></li>
 
−
                                <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Experiments">Experiment</a></li>
 
−
                                <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Results">Results</a></li>
 
−
                                <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Demonstrate">Proof of concept</a></li>
 
−
                            </ul>
 
−
                        </li>
 
−
                        <li class="dropdown">
 
−
                            <a>PARTS <span class="caret"></span></a>
 
−
                            <ul>
 
−
 
−
                                <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Basic_Part">Parts</a></li>
 
−
                                <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Basic_Part">Basic Parts</a></li>
 
−
                                <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Composite_Part">Composite Parts</a></li>
 
−
                                <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Improve">Improve</a></li>
 
−
                            </ul>
 
−
                        </li>
 
−
                        <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Design">Design</a></li>
 
−
                        <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Model">MODELING</a></li>
 
−
                        <li class="SOFTWARE"><a href="https://2017.igem.org/Team:AFCM-Egypt/Software">Software</a></li>
 
−
                        <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Safety">SAFETY</a></li>
 
−
                        <li class="dropdown">
 
−
                            <a>HUMAN PRACTICE <span class="caret"></span></a>
 
−
                            <ul>
 
−
                                <li><a href="https://2017.igem.org/Team:AFCM-Egypt/HP/Silver">Silver</a></li>
 
−
                                <li><a href="https://2017.igem.org/Team:AFCM-Egypt/HP/Gold">Gold</a></li>
 
−
                                <li><a href="https://2017.igem.org/Team:AFCM-Egypt/HP/Integrated">Integrated</a></li>
 
−
 
−
                            </ul>
 
−
                        <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Attributions">ATTRIBUTIONS</a></li>
 
−
                        <li><a href="https://2017.igem.org/Team:AFCM-Egypt/Medal_criteria">MEDAL CRITERIA</a></li>
 
−
                    </ul>
 
−
</div>
 
−
                </div>
 
−
            </div>
 
−
        </nav>
 
−
    </section>
 
 
     <div class="twitter-feed purple" style="padding-bottom:250px">
 
     <div class="twitter-feed purple" style="padding-bottom:250px">
 
         <div class="container section-wrapper" style="padding-top:0px !important;width:90%">
 
         <div class="container section-wrapper" style="padding-top:0px !important;width:90%">
 
             <div class="col-md-12 text-center">
 
             <div class="col-md-12 text-center">
−
                 <video width="1400" height="700" autoplay controls style="width:1400px;height: 700px;">
+
                 <video autoplay controls loop style="width:85%;height:85%">
 
                     <source src="https://static.igem.org/mediawiki/2017/8/88/Final_vid.mp4" type="video/mp4">
 
                     <source src="https://static.igem.org/mediawiki/2017/8/88/Final_vid.mp4" type="video/mp4">
 
                 </video>
 
                 </video>
Line 228: Line 173:
 
                 <div class="col-md-6 text-center" style="float: none;height: auto ; width: 90%; margin: auto; background-color: rgba(0, 0, 0, 0.4);">
 
                 <div class="col-md-6 text-center" style="float: none;height: auto ; width: 90%; margin: auto; background-color: rgba(0, 0, 0, 0.4);">
 
                     <p><img style="float: right;" src="https://static.igem.org/mediawiki/2017/d/d4/CRISPR_PNG.png" alt="" width="679" height="988" /></p>
 
                     <p><img style="float: right;" src="https://static.igem.org/mediawiki/2017/d/d4/CRISPR_PNG.png" alt="" width="679" height="988" /></p>
−
                    <h3 class="text-center" style="text-align: center;"><br /><br /><span style="font-size: 14pt; color: #ffffff;">Abstract</span></h3>
+
<h3 dir="ltr" style="text-align: left;"><span style="font-size: 20pt; color: #ffffff;">Competing endogenous RNA network : Potential entrants to gene editing in Hepatocellular Carcinoma</span><br /><br /><br />               
 +
  <h3 class="text-center" style="text-align: center;"><br /><br /><span style="font-size: 14pt; color: #ffffff;">Abstract</span></h3>
 
                     <p style="text-align: left;"><span style="font-size: 14pt; color: #ffffff;">&nbsp;</span></p>
 
                     <p style="text-align: left;"><span style="font-size: 14pt; color: #ffffff;">&nbsp;</span></p>
−
                    <h3 dir="ltr" style="text-align: left;"><span style="font-size: 14pt; color: #ffffff;">Competing endogenous RNA network : Potential entrants to gene editing in Hepatocellular Carcinoma</span><br /><br /><br /><span style="font-size: 14pt; color: #ffffff;">Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide &amp; ranked first among cancers in males and next to breast cancer among females in</span><span style="font-size: 14pt; color: #ffffff;"> Egypt based upon results of National Cancer Registry Program of Egypt. "Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique that we will be using to modulate a certain&nbsp; circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma. This in consequence modifies&nbsp; &nbsp;miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials.&nbsp; &nbsp;This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is&nbsp; &nbsp; accomplished by utilizing a&nbsp; &nbsp;synthetic circuit to give rise to a springboard in our battle against cancer.</span><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /></h3>
+
                  <span style="font-size: 14pt; color: #ffffff;">Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide &amp; ranked first among cancers in males and next to breast cancer among females in</span><span style="font-size: 14pt; color: #ffffff;"> Egypt based upon results of National Cancer Registry Program of Egypt. "Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique that we will be using to modulate a certain&nbsp; circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma. This in consequence modifies&nbsp; &nbsp;miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials.&nbsp; &nbsp;This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is&nbsp; &nbsp; accomplished by utilizing a&nbsp; &nbsp;synthetic circuit to give rise to a springboard in our battle against cancer.</span><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /></h3>
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>
Line 244: Line 190:
 
                         A Culture of Discipline and Innovation</h3>
 
                         A Culture of Discipline and Innovation</h3>
 
                         <a href="http://www.afcm.ac.eg/" class="btn btn-primary btn-outline with-arrow" target="_blank"> click here <i class="fa fa-arrow-right"></i></a></div>
 
                         <a href="http://www.afcm.ac.eg/" class="btn btn-primary btn-outline with-arrow" target="_blank"> click here <i class="fa fa-arrow-right"></i></a></div>
−
            </div>
 
 
             <div class='col-md-3'><img src="https://static.igem.org/mediawiki/2017/7/7b/AFCM_LOGO_PNG.png" alt="logo" style='width: 50%;float: right'></div>
 
             <div class='col-md-3'><img src="https://static.igem.org/mediawiki/2017/7/7b/AFCM_LOGO_PNG.png" alt="logo" style='width: 50%;float: right'></div>
 
         </div>
 
         </div>
Line 260: Line 205:
 
                     </li>
 
                     </li>
 
                     <li class="afcmslide">
 
                     <li class="afcmslide">
−
                        <img src="https://static.igem.org/mediawiki/2017/b/bb/2-AFCM-Egypt-sponsers-EFIA_LOGO.png" style="width: 150px;padding-right: 15px;">
 
 
                         <img src="https://static.igem.org/mediawiki/2017/3/3b/4-AFCM-Egypt-sponsers-Nationel_Research.png" style="width: 150px;padding-right: 15px;">
 
                         <img src="https://static.igem.org/mediawiki/2017/3/3b/4-AFCM-Egypt-sponsers-Nationel_Research.png" style="width: 150px;padding-right: 15px;">
 
                         <img src="https://static.igem.org/mediawiki/2017/6/67/7-AFCM-Egypt-sponsers-Image-2.jpeg" style="width: 160px;padding-right: 15px;">
 
                         <img src="https://static.igem.org/mediawiki/2017/6/67/7-AFCM-Egypt-sponsers-Image-2.jpeg" style="width: 160px;padding-right: 15px;">
Line 273: Line 217:
 
     </section>
 
     </section>
 
         <button id="myBtn" title="Go to top"><i class="fa fa-arrow-up fa-3x"></i></button>
 
         <button id="myBtn" title="Go to top"><i class="fa fa-arrow-up fa-3x"></i></button>
−
    <script src="https://2017.igem.org/Template:AFCM-Egypt/owl.carouseljs/javascript?action=raw&ctype=text/javascript"></script>
+
 
 
     <script>
 
     <script>
 
$(document).ready(function() {
 
$(document).ready(function() {
Line 295: Line 239:
 
var slides = document.querySelectorAll('#afcmslides .afcmslide');
 
var slides = document.querySelectorAll('#afcmslides .afcmslide');
 
         var currentSlide = 0;
 
         var currentSlide = 0;
−
 
+
var slideInterval ;
 
         var controls = document.querySelectorAll('.afcmcontrols');
 
         var controls = document.querySelectorAll('.afcmcontrols');
  

Latest revision as of 20:11, 31 October 2017

A F C M

A F C M

Competing endogenous RNA network : Potential entrants to gene editing in Hepatocellular Carcinoma




Abstract

 

Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers in males and next to breast cancer among females in Egypt based upon results of National Cancer Registry Program of Egypt. "Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique that we will be using to modulate a certain  circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma. This in consequence modifies   miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials.   This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is    accomplished by utilizing a   synthetic circuit to give rise to a springboard in our battle against cancer.














OUR SPONSORS